BILLS-116hr8662ih.pdf

2020 21:54 Nov 13 5-year September 2019 2026 later than 90 days OCTOBER 23, 2020 8662 IH later than one year later than 18 months 2-year later than 6 months

the ‘‘Collaborative SESSION H. R. 8662 the ‘‘Accelerating Access

PO 00000 Frm 00001 PO 00000 Frm 00005 PO 00000 Frm 00002 PO 00000 Frm 00008 Fmt PO 00000 Frm 00011 Fmt PO 00000 Frm 00007 PO 00000 Frm 00004 PO 00000 Frm 00010 PO 00000 Frm 00009 PO 00000 Frm 00003 Fmt PO 00000 Frm 00006

Nebraska the United States of America Oklahoma Georgia New York Alabama Iowa Washington

IH

SEC Health and Human Services Collaborative the Federal Food, Drug U.S.C. Food, Drug the Food and Drug Administration tional Institutes of Health the Committee on Energy and Commerce the Food and Drug the Commissioner of Food and Drugs THE HOUSE OF REPRESENTATIVES the Center of Excellence for Oncology the National Institutes of Health and Food the Federal Food Food and Drug Administration Health Federal House of Representatives the Public Health Service Act the Department of Health and Human Congress Health, Education GIANFORTE House of Representa- Collaborative for Neurodegenerative FORD Drug ALS Ms. Human Services Project Facilitate the National Institutes of Health Drug Administration Senate National Institutes of APPROPRIATIONS Labor

NORTON SCHWEIKERT ROUDA RUSH AMODEI QUIGLEY BEATTY DAVID SCOTT BACON PETERSON KEVIN HERN CALVERT WESTERMAN •HR UPTON KATKO DIAZ-BALART LOWENTHAL STIVERS SMITH BARRAGA´N FORTENBERRY SEWELL CISNEROS COSTA HAGEDORN WELCH MULLIN MCKINLEY BIGGS SCHIFF FLEISCHMANN RUTHER- TIMMONS MARSHALL

clinical trial trial expanded collaborative bills jbell jbell jbell bills drugs support research clinical drug investiga phase research therapies